Key result
C-type natriuretic peptide (CNP) rapidly stimulated ERK1/2 phosphorylation in pituitary GH3 somatolactotrope cells via a GC-B-dependent but cGMP-independent mechanism.
Why the study?
Does CNP activate the ERK1/2 pathway independently of cGMP in pituitary GH3 cells?
Does CNP activate the ERK1/2 pathway independently of cGMP in pituitary GH3 cells?
CNP activates the ERK1/2 pathway via the GC-B receptor independently of cGMP in pituitary cells, revealing a novel signaling mechanism for particulate guanylyl cyclases.
The natriuretic peptides, Atrial-, B-type and C-type natriuretric peptides (ANP, BNP, CNP), are regulators of many endocrine tissues and exert their effects predominantly through the activation of their specific guanylyl cyclase receptors (GC-A and GC-B) to generate cGMP. Whereas cGMP-independent signalling has been reported in response to natriuretic peptides, this is mediated via either the clearance receptor (Npr-C) or a renal-specific NPR-Bi isoform, which both lack intrinsic guanylyl cyclase activity. Here, we report evidence of GC-B-dependent cGMP-independent signalling in pituitary GH3 cells. Stimulation of GH3 cells with CNP resulted in a rapid and sustained enhancement of ERK1/2 phosphorylation (P-ERK1/2), an effect that was not mimicked by dibutryl-cGMP. Furthermore, CNP-stimulated P-ERK1/2 occurred at concentrations below that required for cGMP accumulation. The effect of CNP on P-ERK1/2 was sensitive to pharmacological blockade of MEK (U0126) and Src kinases (PP2). Silencing of the GC-B1 and GC-B2 splice variants of the GC-B receptor by using targeted short interfering RNAs completely blocked the CNP effects on P-ERK1/2. CNP failed to alter GH3 cell proliferation or cell cycle distribution but caused a concentration-dependent increase in the activity of the human glycoprotein α-subunit promoter (αGSU) in a MEK-dependent manner. Finally, CNP also activated the p38 and JNK MAPK pathways in GH3 cells. These findings reveal an additional mechanism of GC-B signalling and suggest additional biological roles for CNP in its target tissues.
No takes yet. Share an insight, caveat, or question.
Jonas et al. (2017) studied In vitro study (GH3 somatolactotropes). C-type natriuretic peptide (CNP) vs. Control / dibutryl-cGMP was evaluated on ERK1/2 phosphorylation. C-type natriuretic peptide (CNP) rapidly stimulated ERK1/2 phosphorylation in pituitary GH3 somatolactotrope cells via a GC-B-dependent but cGMP-independent mechanism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: